136 related articles for article (PubMed ID: 1744992)
1. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
Hombhanje F
Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
[TBL] [Abstract][Full Text] [Related]
2. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
Zysset T; Peretti E
Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
Hall S
Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
[TBL] [Abstract][Full Text] [Related]
4. N-acetylation phenotyping with sulphadimidine in a Turkish population.
Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
[TBL] [Abstract][Full Text] [Related]
5. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
6. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
7. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
Hadasová E; Brysová V; Utĕsený J; Macků M
Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
[TBL] [Abstract][Full Text] [Related]
8. Polymorphically acetylated aminoglutethimide in humans.
Coombes RC; Foster AB; Harland SJ; Jarman M; Nice EC
Br J Cancer; 1982 Sep; 46(3):340-5. PubMed ID: 7126424
[TBL] [Abstract][Full Text] [Related]
9. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
10. Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.
Rao KV; Mitchison DA; Nair NG; Prema K; Tripathy SP
Br Med J; 1970 Aug; 3(5721):495-7. PubMed ID: 5454342
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration and acetylator phenotype determine response to oral hydralazine.
Shepherd AM; McNay JL; Ludden TM; Lin MS; Musgrave GE
Hypertension; 1981; 3(5):580-5. PubMed ID: 7298112
[TBL] [Abstract][Full Text] [Related]
12. The effect of glucose on acetylation status.
Suhardjono D; Boutagy J; Shenfield GM
Br J Clin Pharmacol; 1986 Oct; 22(4):401-8. PubMed ID: 3768255
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the acetylator and the sparteine hydroxylation polymorphisms.
Harmer D; Evans DA; Eze LC; Jolly M; Whibley EJ
J Med Genet; 1986 Apr; 23(2):155-6. PubMed ID: 3712391
[TBL] [Abstract][Full Text] [Related]
14. Acetylator phenotype and congenital malformations.
Stoll C; Roth MP; Dott B; Doumit N; Alembik Y; Welsch M; Imbs JL
Eur J Clin Pharmacol; 1989; 36(2):151-3. PubMed ID: 2721540
[TBL] [Abstract][Full Text] [Related]
15. Clonazepam acetylation in fast and slow acetylators.
Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
[TBL] [Abstract][Full Text] [Related]
16. Acetylator polymorphism in rheumatoid arthritis.
Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic acetylation of sulphadimidine in normal and uraemic man.
Talseth T; Landmark KH
Eur J Clin Pharmacol; 1977; 11(1):33-6. PubMed ID: 832655
[TBL] [Abstract][Full Text] [Related]
18. A simple pharmacokinetic method for separating the three acetylation phenotypes: a preliminary report.
Lee EJ; Lee LK
Br J Clin Pharmacol; 1982 Mar; 13(3):375-8. PubMed ID: 7059437
[TBL] [Abstract][Full Text] [Related]
19. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
20. Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.
Olsen H; Mørland J
Br Med J; 1978 Nov; 2(6147):1260-2. PubMed ID: 709306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
